Howard Hughes Medical Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2024

  1. GLABRA2 transcription factor integrates arsenic tolerance with epidermal cell fate determination

    New Phytologist

  2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

2023

  1. Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening

    Nature Communications, Vol. 14, Núm. 1

  2. Long non-coding RNAs: definitions, functions, challenges and recommendations

    Nature Reviews Molecular Cell Biology, Vol. 24, Núm. 6, pp. 430-447

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2020

  1. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers

    Open Heart, Vol. 7, Núm. 1

  2. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

    Nature, Vol. 583, Núm. 7817, pp. 609-614

2018

  1. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency

    Journal of Clinical Immunology, Vol. 38, Núm. 4, pp. 513-526

2016

  1. Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi

    Cell

2015

  1. Diltiazem treatment for pre-Clinical hypertrophic cardiomyopathy sarcomereMutation carriers: A pilot randomized trial to modify disease expression

    JACC: Heart Failure, Vol. 3, Núm. 2, pp. 180-188

2014

  1. Admixture facilitates genetic adaptations to high altitude in Tibet

    Nature Communications, Vol. 5

  2. Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

    Clinical Cancer Research, Vol. 20, Núm. 8, pp. 2092-2103

  3. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

    Blood, Vol. 124, Núm. 19, pp. 2937-2947

2013

  1. IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression

    PLoS ONE, Vol. 8, Núm. 7

2012

  1. The Genetic Architecture of Adaptations to High Altitude in Ethiopia

    PLoS Genetics, Vol. 8, Núm. 12

2011

  1. Adaptations to climate-mediated selective pressures in humans

    PLoS Genetics, Vol. 7, Núm. 4

  2. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

2010

  1. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy

    New England Journal of Medicine, Vol. 363, Núm. 6, pp. 552-563

2000

  1. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production

    Journal of Experimental Medicine, Vol. 191, Núm. 12, pp. 2113-2120